NASDAQ : PGNY

Progyny, Inc. — Institutional Ownership

$31.19 USD

$0.49 (1.6%)

Volume
644.56K
Average Volume
1.49M
Market Capitalization
$2.44B
P/E Ratio
38.51
Dividend Yield
0.00%
Price Target
$35.00
Year High
$33.07
Year Low
$16.10
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.13
Institutional Ownership Summary
Institutional Ownership %

7.12%

Investors Holding

49

change: -247 | last: 296
Increased Positions

21

change: -144 | last: 165
Reduced Positions

18

change: -67 | last: 85
New Positions

6

change: -41 | last: 47
Sold Positions

249

change: 181 | last: 68
Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -49.6318 | last: 0.4963
Total Invested

158.68M

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-06-08 KPCB XIII Associates, LLC - 0.00%
2026-06-08 KLEINER PERKINS CAUFIELD & BYERS XIII, LLC - 0.00%
2026-04-29 Vanguard Portfolio Management 5.36M 6.54%
2026-03-27 The Vanguard Group - 0.00%
2025-11-05 FMR LLC 6.57M 7.60%
2025-08-06 FMR LLC 4.71M 5.50%
2025-07-29 The Vanguard Group 9.87M 11.51%
2025-05-14 TPG GP A, LLC - 0.00%
2025-04-29 THRIVENT FINANCIAL FOR LUTHERANS 5.35M 6.30%
2025-04-28 BlackRock, Inc. 11.15M 13.00%
2024-11-08 (1) BlackRock, Inc. 14.03M 15.50%
2022-02-14 13-3017981 4.56M 5.00%
2022-02-11 Kleiner Perkins Caufield & Byers XIII, LLC (“KPCB XIII”) 6.47M 7.20%
2022-02-11 Winkelried 10.57M 11.60%
2022-02-11 KPCB XIII Associates, LLC 6.47M 7.20%
2022-02-11 Bonderman 10.57M 11.60%
2022-02-11 G. Coulter 10.57M 11.60%
2022-02-11 GP A, LLC 10.57M 11.60%
2022-02-10 The Vanguard Group - 23-1945930 6.48M 7.16%
2022-02-04 (1) BlackRock, Inc. 7.92M 8.80%
2021-03-02 David J. Schlanger 5.88M 6.30%
2021-02-16 Kleiner Perkins Caufield & Byers XIII, LLC (“KPCB XIII”) 11.62M 13.40%
2021-02-16 KPCB XIII Associates, LLC 11.62M 13.40%
2021-02-16 Alger Group Holdings, LLC 4.52M 5.22%
2021-02-16 13-3017981 4.52M 5.22%
2021-02-12 GlaxoSmithKline plc 2.93M 3.40%
2021-02-12 2 15.29M 17.50%
2021-02-12 2 15.29M 17.50%
2021-02-12 2 15.29M 17.50%
2021-02-12 10. 5.39M 6.22%
2021-02-12 10. 5.39M 6.22%
2021-02-12 10. 5.39M 6.22%
2021-02-12 10. 5.39M 6.22%
2021-02-12 5.98% 5.18M 5.98%
2020-02-14 GlaxoSmithKline plc 10.53M 12.50%
2020-02-13 David Bonderman 20.66M 24.40%
2020-02-13 James G. Coulter 20.66M 24.40%
2020-02-13 TPG Group Holdings (SBS) Advisors, Inc. 20.66M 24.40%
2020-02-13 KPCB XIII Associates, LLC 18.15M 21.60%
2020-02-13 Kleiner Perkins Caufield & Byers XIII, LLC (“KPCB XIII”) 18.15M 21.60%
2020-02-11 Merck B.V. 4.3M 5.10%
2020-02-11 Merck KGaA 4.3M 5.10%
2020-02-11 Merck Ventures B.V. 4.3M 5.10%
PGNY Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $25.68 85.23M $2.19B $112.24M $27.73M $2.1B
2024-12-31 $17.25 91.48M $1.58B $162.31M $19.27M $1.44B
2023-12-31 $37.18 95.02M $3.53B $97.3M $19.39M $3.45B
2022-12-31 $31.15 92.2M $2.87B $120.08M $7.71M $2.76B
2021-12-31 $50.35 89.11M $4.49B $91.41M $8.65M $4.4B
2020-12-31 $42.39 85.72M $3.63B $70.3M $9.55M $3.57B
2019-12-31 $27.45 83.57M $2.29B $80.38M -$ $2.21B
2018-12-31 $15.94 81.56M $1.3B $127K $253K $1.3B
2017-12-31 $15.94 5.69M $90.7M $4.69M $5.19M $91.2M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $16.98 80.92M $1.37B $132.65M $27.28M $1.27B
2025-12-31 $25.68 85.23M $2.19B $112.24M $27.73M $2.1B
2025-09-30 $21.52 86.02M $1.85B $133.98M $28.15M $1.75B
2025-06-30 $22.00 85.77M $1.89B $132.51M $25.5M $1.78B
2025-03-31 $22.34 85.5M $1.91B $109.24M $26M $1.83B
2024-12-31 $17.25 91.48M $1.58B $162.31M $19.27M $1.44B
2024-09-30 $16.76 90.07M $1.51B $91.48M $16.62M $1.43B
2024-06-30 $28.38 93.87M $2.66B $94.96M $19.87M $2.59B
2024-03-31 $36.51 96.48M $3.52B $114.96M $19.29M $3.43B
2023-12-31 $37.18 95.98M $3.57B $97.3M $19.39M $3.49B
2023-09-30 $34.02 95.5M $3.25B $158.08M $17.7M $3.11B
2023-06-30 $39.34 94.74M $3.73B $170.57M $18.14M $3.57B